期刊文献+

阿卡波糖联合二甲双胍对2型糖尿病患者相关指标的影响 被引量:41

Effects of Acarbose Combined with Metformin on Related Indexes of Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的:探讨阿卡波糖联合二甲双胍对2型糖尿病患者相关指标的影响。方法:100例2型糖尿病患者随机分为对照组(50例)和观察组(50例)。对照组患者给予阿卡波糖片50 mg,口服,每日3次;观察组患者在对照组治疗的基础上给予盐酸二甲双胍片0.5 g,口服,每日3次。两组疗程均为12周。观察两组患者治疗前后空腹血糖(FPG)、空腹血浆胰岛素(FINS)、糖化血红蛋白(Hb A1c)、餐后2 h血糖(2 h PG)、餐后2 h胰岛素(2 h FINS)、胰岛素抵抗指数(HOMA-IR)、CD4^+T细胞中各Th细胞亚群比例、白细胞介素22(IL-22)、IL-17A、干扰素-γ(IFN-γ)水平及IL-22 m RNA、IL-17A m RNA、IFN-γm RNA表达水平,并记录不良反应发生情况。结果:治疗后,两组患者FPG、FINS、Hb A1c、2 h PG、2 h FINS、HOMA-IR、CD4^+T细胞中各Th细胞亚群比例、IL-22、IL-17A、IFN-γ水平及IL-22 m RNA、IL-17A m RNA、IFN-γm RNA表达水平均显著低于同组治疗前,差异均有统计学意义(P<0.05);两组间除CD4^+T细胞中Th1细胞亚群比例比较差异无统计学意义(P>0.05)外,其他指标均为观察组显著低于对照组,差异均有统计学意义(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:阿卡波糖联合二甲双胍可有效控制2型糖尿病患者的血糖,改善胰岛抵抗状态,平衡Th细胞亚群,降低炎性细胞因子水平,且未增加不良反应的发生。 OBJECTIVE: To investigate the effects of acarbose combined with metfonnin on related indexes of patients with type 2 diabetes mellitus. METHODS: A total of 100 patienls with type 2 diabetes mellitus were randomly divided into control group (50 cases) and observation group (50 cases). Control group was given Acrbose tablet 50 mg orally, 3 times a day. Observa- lion group was additionally given Metformin hydrochloride tablet 0.5 g orally, 3 times a day, on the basis of control group. Both groups were treated for 12 weeks. The levels of fasting plasma glucose (FPG), fasting plasma insulin (FINS), glycosylated he- moglobin (HbA,c), 2 11 postprandial plasma glucose (2 hPG), postprandial 2 h insulin (2 hFINS), insulin resistance index (HOMA-IR), the proportion of Th cell subsets in CD,1~ T cells,lL-22,1L-17A and IFN-~,, mRNA expression of 1L-22,1L-17A and IFN-T were observed in 2 groups before and after treatment. The occurrence of ADR was recorded. RESULTS: After treatment, FPG, FINS, HbA1c, 2 hPG, 2 hFINS, HOMA-IR, the proportion of Th cell subsets in CD4^+T cells, the concentrations of IL-22, IL-I 7A and IFN-7, expression of IL-22 mRNA, IL-17A mRNA and IFN-3, mRNA in 2 groups were significantly lower than before Ireatment, with statistical significance (P〈0.05) ; there was no significant difference in the proportion of Thl in T cells between 2 groups(P〉0.05). Other indexes of observation group were signifcantly lower than those of control group, with statistical signifi- cance (P〈0.05). There was no statistical significance in the incidence of ADR between 2 groups (P〉0.05). CONCLUSIONS: For patients with type 2 diabetes mellitus, acarbose combined with mefformin can effectively control the level of blood glucose, im- prove insulin resistance, balance Th cell subsets, reduce inflammatory factors levels but don't increase the occurrence of ADR.
出处 《中国药房》 CAS 北大核心 2017年第27期3774-3777,共4页 China Pharmacy
基金 广东省中医药局科研课题(No.20142062)
关键词 阿卡波糖 二甲双胍 2型糖尿病 CD4^+T细胞亚群 炎性细胞因子 胰岛素抵抗 血糖 Acarbose Metformin Type 2 diabetes mellitus CD4^+ T cell subset Inflammatory factors Insulin resistance Blood glucose
  • 相关文献

参考文献6

二级参考文献115

共引文献3683

同被引文献245

引证文献41

二级引证文献237

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部